tirzepatide phase 3 study results Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, trial Tirzepatide for the treatment of

To protect vital tissues and organs from this intense oxidative onslaught, the body rapidly consumes its intracellular stores of glutathione

Dr Greg Ong has clinical appointments at Fiona Stanley Hospital, Fremantle Hospital, and Sir Charles Gairdner Hospital where he previously served as clinical lead (Director) of Acute Internal Medicine

IGF-1 and Longevity Research has shown that while decreased levels of GH and IGF-1 lead to the deterioration of various physiological functions, these decreased levels have also shown promise in increasing life span

They are not recommended for people with certain medical conditions, medications or family history

IV therapy delivers essential vitamins, minerals, and hydration directly into the bloodstream, allowing for faster absorption and more effective results

Tirzepatide is available in doses of 5 mg, 10 mg, and 15 mg, 30 mg enabling researchers to select a suitable quantity depending on the study and analytical requirements